# TACTiC Study — A study for high cholesterol.

> Research study for a high cholesterol treatment product. (iPhone/iPad app by Hello Thread.)

- Source: https://appshunter.io/ios/app/tactic-study/id1563397289 (this page in markdown: same URL + `.md`)
- Developer: [Hello Thread](https://appshunter.io/developer/996237890)
- Category: Medical
- Price: Free
- Rating: 5.00/5 from 2 App Store ratings
- Age rating: 17+
- Requires: iOS 11.0 · 153 MB
- Languages: Afrikaans, Amharic, Arabic, Belarusian, Bulgarian, Croatian, Czech, Danish, Dutch, English and 37 more
- Released: 2021-07-07
- Data updated: 2026-06-10
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/tactic-study/id1563397289/reviews.md

## What is TACTiC Study?

TACTiC Study is a research study for a healthcare product for the treatment of high cholesterol that is currently available by prescription but may become available over-the-counter.

## Key features

- High cholesterol treatment research
- Healthcare product study
- Prescription to over-the-counter transition
- Medical research participation


## Frequently asked questions about TACTiC Study

### What is TACTiC Study for?

TACTiC Study is a research study focused on a healthcare product designed to treat high cholesterol. The product is currently available by prescription and may transition to over-the-counter availability.

### Is TACTiC Study free to use?

Yes, TACTiC Study is a free application. There are no costs associated with downloading or using the app itself.

### What devices does TACTiC Study support?

TACTiC Study is available on iPhone, iPad, and iPod devices.

### What is the age rating for TACTiC Study?

TACTiC Study has an age rating of 17+, indicating it is intended for mature audiences.

### How often is TACTiC Study updated?

The latest version of TACTiC Study was released on June 27, 2022. Updates are provided by the developer Hello Thread to improve the application.

### What is the user sentiment for TACTiC Study?

Based on available data, TACTiC Study has received a perfect 5.0-star rating from 2 reviews, suggesting a very positive user reception.

### Does TACTiC Study have ads?

No, TACTiC Study does not contain advertisements. The application is ad-free.

### Who developed TACTiC Study?

TACTiC Study was developed by Hello Thread, a company focused on healthcare products and research.

## Version history (last 4 releases)

### 1.3 — 2022-06-27

Study survey update.

### 1.2 — 2022-04-19

Minor bug fixes.

### 1.1 — 2022-04-04

Study survey update and minor bug fixes

### 1.0 — 2021-07-07

No release notes.

## Apps similar to TACTiC Study

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [Shoulder Innovations](https://appshunter.io/ios/app/shoulder-innovations/id1547031979) | — | Free | Medical |
| [Vision Engage](https://appshunter.io/ios/app/vision-engage/id6443581547) | 4.8 (6,284) | Free | Medical |
| [Patient Cloud](https://appshunter.io/ios/app/patient-cloud/id1361329140) | 2.7 (112) | Free | Medical |
| [Kardia](https://appshunter.io/ios/app/kardia/id579769143) | 4.8 (217,152) | Free | Medical |
| [YPrime](https://appshunter.io/ios/app/yprime/id1659475338) | — | Free | Medical |
| [Curebase](https://appshunter.io/ios/app/curebase/id1437100130) | 5.0 (3) | Free | Medical |

## More apps by Hello Thread

- [The Duchenne Registry](https://appshunter.io/ios/app/the-duchenne-registry/id1473205578)
- [IED Log](https://appshunter.io/ios/app/ied-log/id1500234267)
- [HELIOS-A](https://appshunter.io/ios/app/helios-a/id1528146060)
- [FINEARTS-HF #20103](https://appshunter.io/ios/app/finearts-hf-20103/id1536715345)
- [Abbott SMBG Study](https://appshunter.io/ios/app/abbott-smbg-study/id1536721001)
- [T1D Trial](https://appshunter.io/ios/app/t1d-trial/id1540940479)

All apps by Hello Thread: https://appshunter.io/developer/996237890

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-10.*